Search Results - "Władysiuk, Magdalena"

Policies for biosimilar uptake in Europe: An overview by Moorkens, Evelien, Vulto, Arnold G, Huys, Isabelle, Dylst, Pieter, Godman, Brian, Keuerleber, Simon, Claus, Barbara, Dimitrova, Maria, Petrova, Guenka, Sović-Brkičić, Ljiljana, Slabý, Juraj, Šebesta, Robin, Laius, Ott, Karr, Allan, Beck, Morgane, Martikainen, Jaana E, Selke, Gisbert W, Spillane, Susan, McCullagh, Laura, Trifirò, Gianluca, Vella Bonanno, Patricia, Mack, Asbjørn, Fogele, Antra, Viksna, Anita, Władysiuk, Magdalena, Mota-Filipe, Helder, Meshkov, Dmitry, Kalaba, Marija, Mencej Bedrač, Simona, Fürst, Jurij, Zara, Corrine, Skiöld, Peter, Magnússon, Einar, Simoens, Steven

“…Across European countries, differences exist in biosimilar policies, leading to variations in uptake of biosimilars and divergences in savings all over Europe…”
Get full text

Indirect Costs of Rheumatoid Arthritis Depending on Type of Treatment-A Systematic Literature Review by Batko, Bogdan, Rolska-Wójcik, Paulina, Władysiuk, Magdalena

“…The economic burden of rheumatoid arthritis (RA) on society is high. Disease-modifying antirheumatic drugs (DMARDs) are the cornerstone of therapy. Biological…”
Get full text

Inflammatory markers in pregnant women with periodontal diseases—Systematic review and network meta‐analysis by Kania, Michal, Malinowski, Krzysztof Piotr, Słowik, Joanna, Władysiuk, Magdalena, Szopa, Magdalena

“…Periodontal diseases (PD) have been associated with adverse pregnancy outcomes. Several studies reported on cytokines concentrations and oxidative stress in…”
Get full text

Economic and social cost of epilepsy in Poland: 5-year analysis by Jędrzejczak, Joanna, Majkowska-Zwolińska, Beata, Chudzicka-Bator, Anna, Żerda, Iwona, Władysiuk, Magdalena, Godman, Brian

“…Introduction Epilepsy affects nearly 50 million people around the world. As a common and chronic disease generates a high cost burden for healthcare system and…”
Get full text

Analysis of changes in drug reimbursement based on the example of the limit groups containing beta-2 adrenergic drugs in Poland in the years 2012-2021 by Rykowski, Piotr, Władysiuk, Magdalena, Plisko, Robert, Stańczak, Andrzej

“…Subject of the study The subject of the study is a price analysis of the limit groups of reimbursed beta-2 adrenergic drugs. Rationalisation of reimbursement…”
Get full text

What matters in treating non‐oncological rare diseases?—Eliciting experts' preferences in Poland with PAPRIKA by Jakubczyk, Michał, Niewada, Maciej, Plisko, Robert, Władysiuk, Magdalena, Jachimowicz, Michał, Pruszko, Cezary, Wepsięć, Katarzyna, Lis, Joanna

“…Value in drugs do not always lies simply in them curing diseases: they may also be used to prolong life, improve its quality, and relieve patients' families…”
Get full text

Personalizing health care: feasibility and future implications by Godman, Brian, Finlayson, Alexander E, Cheema, Parneet K, Zebedin-Brandl, Eva, Gutiérrez-Ibarluzea, Inaki, Jones, Jan, Malmström, Rickard E, Asola, Elina, Baumgärtel, Christoph, Bennie, Marion, Bishop, Iain, Bucsics, Anna, Campbell, Stephen, Diogene, Eduardo, Ferrario, Alessandra, Fürst, Jurij, Garuoliene, Kristina, Gomes, Miguel, Harris, Katharine, Haycox, Alan, Herholz, Harald, Hviding, Krystyna, Jan, Saira, Kalaba, Marija, Kvalheim, Christina, Laius, Ott, Lööv, Sven-Ake, Malinowska, Kamila, Martin, Andrew, McCullagh, Laura, Nilsson, Fredrik, Paterson, Ken, Schwabe, Ulrich, Selke, Gisbert, Sermet, Catherine, Simoens, Steven, Tomek, Dominik, Vlahovic-Palcevski, Vera, Voncina, Luka, Wladysiuk, Magdalena, van Woerkom, Menno, Wong-Rieger, Durhane, Zara, Corrine, Ali, Raghib, Gustafsson, Lars L

“…Considerable variety in how patients respond to treatments, driven by differences in their geno- and/ or phenotypes, calls for a more tailored approach. This…”
Get full text

Guidance for the occupational medicine service regarding the prevention of hepatitis C and HIV infection in Poland by Marcinkiewicz, Andrzej, Walusiak-Skorupa, Jolanta, Wdówik, Paweł, Zarębska-Michaluk, Dorota, Inglot, Małgorzata, Władysiuk, Magdalena, Prycel, Tomasz Jan, Flisiak, Robert

Get full text

Indirect costs of atopic dermatitis (AD) – systematic review and Polish perspective by Plisko, Robert, Polkowska, Marta, Lis, Joanna

“…OBJECTIVE: Atopic dermatitis (AD) is a common chronic, pruritic inflammatory skin disease. It is associated with a high personal burden of illness and economic…”
Get full text

Treatment options in chronic lymphocytic leukemia (CLL) – a Polish perspective by Monica, Magdalena, Władysiuk, Magdalena, Hus, Iwona

“…Chronic lymphocytic leukemia (CLL) is the most frequent type of leukemia among the elderly people in Western societies. CLL is genetically and molecularly…”
Get full text

Hepatitis C – the implications and the need for change in the health care system in Poland by Władysiuk, Magdalena, Hałdaś, Mateusz

“…Hepatitis C is a disease spreading across the world. It is estimated that more than 185 million people are potentially infected with HCV. Each year…”
Get full text

Cost minimisation analysis – a simple concept, yet difficult to implement. Too simple CMA can lead to unauthorized conclusions by Plisko, Robert, Drzał, Robert, Władysiuk, Magdalena, Bernaszuk, Ewelina, Lis, Joanna

“…Background: AOTMiT's Health Technology Assessment guidelines developed in Poland in 2007 along with their subsequent updates do not specify how a cost…”
Get full text

Altered tissue electrical properties in women with breast cancer--preliminary observations by Małecka-Massalska, Teresa, Chara, Krzysztof, Gołębiowski, Paweł, Władysiuk, Magdalena, Smoleń, Agata, Kurylcio, Andrzej, Zuchora, Beata, Zubrzycki, Jarosław, Orłowska-Kowalik, Grażyna, Lupa-Zatwarnicka, Krystyna, Polkowski, Wojciech

“…In the United States, breast cancer (BC) is the most common non-skin cancer. In Poland, it is estimated that the number of new breast cancer cases affects…”
Get full text

Can We Determine the Optimal Cycle Length for Which Half-Cycle Correction Should Always Be Applied? by Drzał, Robert, Parker, Mark, Plisko, Robert, Władysiuk, Magdalena

“…Objective: The aim of the study is to measure the influence of cycle length and progression rates on differences between final results obtained using different…”
Get full text

The costs of asthma in Poland in 2012 by Jahnz-Różyk, Karina, Kucharczyk, Aleksandra, Warchoł, Marta, Radziwilska-Muc, Anna, Władysiuk, Magdalena, Plisko, Robert

“…The costs incurred for treatment of patients with asthma are an important part of health care in the budget of each country. The aim of the study was to…”
Get more information

Productivity loss as a result of rheumatic diseases – absenteeism and presenteeism by Raciborski, Filip, Władysiuk, Magdalena, Bebrysz, Magdalena, Samoliński, Bolesław

“…Choroby reumatyczne wpływają nie tylko na zdrowie chorego, lecz także na jego życie prywatne i zawodowe. Wyniki badań pokazują, iż schorzenia te powodują…”
Get full text

Health economics of inhibitor bypassing agents in haemophilia A-activated prothrombin complex concentrate (aPCC) and recombinant activated factor VIIa (rFVIIa) by Szmurło, Daria, Deryło, Łukasz, Ryś, Przemysław, Władysiuk, Magdalena

“…Haemophilia A is a sex-linked recessive genetic disorder associated with haemorrhagic diathesis due to reduced plasma activity of coagulation factor VIII,…”
Get more information

Dabigatran - a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs by Malmström, Rickard E, Godman, Brian B, Diogene, Eduard, Baumgärtel, Christoph, Bennie, Marion, Bishop, Iain, Brzezinska, Anna, Bucsics, Anna, Campbell, Stephen, Ferrario, Alessandra, Finlayson, Alexander E, Fürst, Jurij, Garuoliene, Kristina, Gomes, Miguel, Gutiérrez-Ibarluzea, Iñaki, Haycox, Alan, Hviding, Krystyna, Herholz, Harald, Hoffmann, Mikael, Jan, Saira, Jones, Jan, Joppi, Roberta, Kalaba, Marija, Kvalheim, Christina, Laius, Ott, Langner, Irene, Lonsdale, Julie, Lööv, Sven-Äke, Malinowska, Kamila, McCullagh, Laura, Paterson, Ken, Markovic-Pekovic, Vanda, Martin, Andrew, Piessnegger, Jutta, Selke, Gisbert, Sermet, Catherine, Simoens, Steven, Tulunay, Cankat, Tomek, Dominik, Vončina, Luka, Vlahovic-Palcevski, Vera, Wale, Janet, Wilcock, Michael, Wladysiuk, Magdalena, van Woerkom, Menno, Zara, Corrine, Gustafsson, Lars L

“…There are potential conflicts between authorities and companies to fund new premium priced drugs especially where there are safety and/or budget concerns…”
Get full text

Introduction and Utilization of High Priced HCV Medicines across Europe; Implications for the Future by de Bruijn, Winnie, Ibáñez, Cristina, Frisk, Pia, Bak Pedersen, Hanne, Alkan, Ali, Vella Bonanno, Patricia, Brkičić, Ljiljana S, Bucsics, Anna, Dedet, Guillaume, Eriksen, Jaran, Fadare, Joseph O, Fürst, Jurij, Gallego, Gisselle, Godói, Isabella P, Guerra Júnior, Augusto A, Gürsöz, Hakkı, Jan, Saira, Jones, Jan, Joppi, Roberta, Kerman, Saim, Laius, Ott, Madzikwa, Newman, Magnússon, Einar, Maticic, Mojca, Markovic-Pekovic, Vanda, Massele, Amos, Ogunleye, Olayinka, O'Leary, Aisling, Piessnegger, Jutta, Sermet, Catherine, Simoens, Steven, Tiroyakgosi, Celda, Truter, Ilse, Thyberg, Magnus, Tomekova, Kristina, Wladysiuk, Magdalena, Vandoros, Sotiris, Vural, Elif H, Zara, Corinne, Godman, Brian

“…Infection with the Hepatitis C Virus (HCV) is a widespread transmittable disease with a diagnosed prevalence of 2.0%. Fortunately, it is now curable in most…”
Get full text

'HTA for Crisis': sharing experiences during the 7th EBHC Symposium by Wladysiuk, Magdalena, Tabor, Anna, Godman, Brian

“…The Central and Eastern European Society of Technology Assessment in Health Care was founded in Krakow, Poland in 2003. On October 8th and 9th, the 7th…”
Get more information